India Coronavirus Dispatch: Oxford vaccine may be a better fit for India

Delhi cemetary running out of space, 74 per cent Delhiites say they want markets shut, Covid immune response is enduring, may protect for decades-news on how the country is coping with the pandemic

Expert Speak: Oxford Vaccine May Better Fit India Than Pfizer’s or Moderna’s

Shedding light on the suitability of the various Covid-19 vaccine candidates under development, the noted vaccine scientist Gagandeep Kang said that the Pfizer/BioNTech vaccine, which a Pfizer press release claimed to be more than 90% effective, is “very unlikely to be a solution for India”. This is because India simply does not have the cold storage facilities required to store and transport this vaccine at -70 degrees Celsius to -80 degrees Celsius. The Pfizer vaccine also has a limited shelf life – at times as little as 24-48 hours.